X0202 4 2006-01-04 1 0001013351 MAXIM PHARMACEUTICALS INC MAXM 0001220363 ZERBE ROBERT L MD C/O MAXIM PHARMACEUTICALS, INC. 8899 UNIVERSITY CENTER LANE, SUITE 400 SAN DIEGO CA 92122 1 0 0 0 Employee Stock Option (Right to Buy) 9.60 2006-01-04 4 D 0 20000 D 2014-02-19 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 3.25 2006-01-04 4 D 0 25000 D 2013-02-20 Common Stock 25000 0 D Employee Stock Option (Right to Buy) 3.25 2006-01-04 4 D 0 20000 D 2013-02-20 Common Stock 20000 0 D Employee Stock Option (Right to Buy) 1.64 2006-01-04 4 D 0 20000 D 2015-02-18 Common Stock 20000 0 D [Reserved]. The option vested 100% on 9/30/04. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $47.07 per share. The option vested 100% on date of Grant. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 5,099 shares of EpiCept common stock for $15.94 per share. The option vested 100% on 9/30/03. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $15.94 per share. The option vested 100% on 9/30/05. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $8.05 per share. /s/ John D. Prunty, Attorney-in-Fact 2006-01-06